Verspaget HW - Search Results

1

Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence.

Hawinkels LJ, Verspaget HW, van der Reijden JJ, van der Zon JM, Verheijen JH, Hommes DW, Lamers CB, Sier CF. Hawinkels LJ, et al. Among authors: verspaget hw. Cancer Sci. 2009 Apr;100(4):663-70. doi: 10.1111/j.1349-7006.2009.01100.x. Cancer Sci. 2009. PMID: 19462508 Free PMC article.

2

VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.

Hawinkels LJ, Zuidwijk K, Verspaget HW, de Jonge-Muller ES, van Duijn W, Ferreira V, Fontijn RD, David G, Hommes DW, Lamers CB, Sier CF. Hawinkels LJ, et al. Among authors: verspaget hw. Eur J Cancer. 2008 Sep;44(13):1904-13. doi: 10.1016/j.ejca.2008.06.031. Epub 2008 Aug 6. Eur J Cancer. 2008. PMID: 18691882

3

Circulating cell death products predict clinical outcome of colorectal cancer patients.

Koelink PJ, Lamers CB, Hommes DW, Verspaget HW. Koelink PJ, et al. Among authors: verspaget hw. BMC Cancer. 2009 Mar 23;9:88. doi: 10.1186/1471-2407-9-88. BMC Cancer. 2009. PMID: 19302716 Free PMC article.

4

5-Aminosalicylic acid inhibits TGF-beta1 signalling in colorectal cancer cells.

Koelink PJ, Hawinkels LJ, Wiercinska E, Sier CF, ten Dijke P, Lamers CB, Hommes DW, Verspaget HW. Koelink PJ, et al. Among authors: verspaget hw. Cancer Lett. 2010 Jan 1;287(1):82-90. doi: 10.1016/j.canlet.2009.05.033. Epub 2009 Jun 21. Cancer Lett. 2010. PMID: 19541409

5

Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis.

Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, Sier CF, ten Dijke P. Hawinkels LJ, et al. Among authors: verspaget hw. Cancer Res. 2010 May 15;70(10):4141-50. doi: 10.1158/0008-5472.CAN-09-4466. Epub 2010 Apr 27. Cancer Res. 2010. PMID: 20424116

6

Association of aneuploidy in index adenomas with metachronous colorectal adenoma development and a comparison.

Griffioen G, Cornelisse CJ, Verspaget HW, Sier CF, Eulderink F, Bosman FT, Lamers CB. Griffioen G, et al. Among authors: verspaget hw. Cancer. 1992 Oct 15;70(8):2035-43. doi: 10.1002/1097-0142(19921015)70:8<2035::aid-cncr2820700804>3.0.co;2-y. Cancer. 1992. PMID: 1394033

7

Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.

de Bruin PA, Verspaget HW, Griffioen G, Verheijen JH, Dooijewaard G, Lamers CB. de Bruin PA, et al. Among authors: verspaget hw. Br J Cancer. 1989 Sep;60(3):397-400. doi: 10.1038/bjc.1989.293. Br J Cancer. 1989. PMID: 2506920 Free PMC article.

8

Plasminogen activators in (pre)malignant conditions of the colorectum.

Verspaget HW, Verheijen JH, de Bruin PA, Griffioen G, Lamers CB. Verspaget HW, et al. Eur J Cancer Clin Oncol. 1989 Mar;25(3):565-9. doi: 10.1016/0277-5379(89)90272-1. Eur J Cancer Clin Oncol. 1989. PMID: 2649380 Review.

9

Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.

Sier CF, Vloedgraven HJ, Griffioen G, Ganesh S, Nagengast FM, Lamers CB, Verspaget HW. Sier CF, et al. Among authors: verspaget hw. Br J Cancer. 1995 Feb;71(2):393-6. doi: 10.1038/bjc.1995.80. Br J Cancer. 1995. PMID: 7841059 Free PMC article.

10

Prognostic value of the plasminogen activation system in patients with gastric carcinoma.

Ganesh S, Sier CF, Heerding MM, van Krieken JH, Griffioen G, Welvaart K, van de Velde CJ, Verheijen JH, Lamers CB, Verspaget HW. Ganesh S, et al. Among authors: verspaget hw. Cancer. 1996 Mar 15;77(6):1035-43. doi: 10.1002/(sici)1097-0142(19960315)77:6<1035::aid-cncr5>3.0.co;2-g. Cancer. 1996. PMID: 8635120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

277 results

Search Page

Filters